Comparison of Outcomes of Phase II Studies and Subsequent Randomized Control Studies Using Identical Chemotherapeutic Regimens

作者: Mohammad I. Zia , Lillian L. Siu , Greg R. Pond , Eric X. Chen

DOI: 10.1200/JCO.2005.06.679

关键词:

摘要: Purpose To determine whether promising results from phase II studies could be reproduced in III studies, and to examine which characteristics of might predictive value for subsequent studies. Methods We searched all chemotherapy advanced solid malignancies, published the English language literature July 1998 June 2003. Each study was reviewed identify preceding Phase included this analysis must have used identical regimens. Data were extracted both Results Of 181 identified, 43 therapeutic regimens those 49 Twelve (28%) “positive.” The vast majority (81%) lower response rates than with a mean difference 12.9% among analyzed. None evaluated s...

参考文章(109)
Paul B. Chapman, Lawrence H. Einhorn, Michael L. Meyers, Scott Saxman, Alicia N. Destro, Katherine S. Panageas, Colin B. Begg, Sanjiv S. Agarwala, Lynn M. Schuchter, Marc S. Ernstoff, Alan N. Houghton, John M. Kirkwood, Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma Journal of Clinical Oncology. ,vol. 17, pp. 2745- 2751 ,(1999) , 10.1200/JCO.1999.17.9.2745
Robert J. Motzer, Barbara A. Murphy, Jennifer Bacik, Lawrence H. Schwartz, David M. Nanus, Tania Mariani, Patrick Loehrer, George Wilding, Diane L. Fairclough, David Cella, Madhu Mazumdar, Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma Journal of Clinical Oncology. ,vol. 18, pp. 2972- 2980 ,(2000) , 10.1200/JCO.2000.18.16.2972
Frank V Fossella, Jin Soo Lee, Dong M Shin, Maria Calayag, Martin Huber, Roman Perez-Soler, William K Murphy, Scott Lippman, Steven Benner, Bonnie Glisson, None, Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 13, pp. 645- 651 ,(1995) , 10.1200/JCO.1995.13.3.645
Edward T. Creagan, Vera J. Suman, Robert J. Dalton, Henry C. Pitot, Harry J. Long, Michael H. Veeder, Allen M. Vukov, Kendrith M. Rowland, James E. Krook, John C. Michalak, Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma. Journal of Clinical Oncology. ,vol. 17, pp. 1884- 1890 ,(1999) , 10.1200/JCO.1999.17.6.1884
John P. Chute, Timothy Chen, Ellen Feigal, Richard Simon, Bruce E. Johnson, Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible Progress Journal of Clinical Oncology. ,vol. 17, pp. 1794- 1794 ,(1999) , 10.1200/JCO.1999.17.6.1794
M.R. Middleton, J.J. Grob, N. Aaronson, G. Fierlbeck, W. Tilgen, S. Seiter, M. Gore, S. Aamdal, J. Cebon, A. Coates, B. Dreno, M. Henz, D. Schadendorf, A. Kapp, J. Weiss, U. Fraass, P. Statkevich, M. Muller, N. Thatcher, Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Journal of Clinical Oncology. ,vol. 18, pp. 158- 166 ,(2000) , 10.1200/JCO.2000.18.1.158
C D Blanke, B Kasimis, P Schein, R Capizzi, M Kurman, Phase II Study of Trimetrexate, Fluorouracil, and Leucovorin for Advanced Colorectal Cancer Journal of Clinical Oncology. ,vol. 15, pp. 915- 920 ,(1997) , 10.1200/JCO.1997.15.3.915
Jacek Jassem, Tadeusz Pieńkowski, Anna Płuzańska, Svetislav Jelic, Vera Gorbunova, Zrinka Mrsic-Krmpotic, Juris Berzins, Tomas Nagykalnai, Nelly Wigler, Josette Renard, Stephane Munier, Catherine Weil, Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial Journal of Clinical Oncology. ,vol. 19, pp. 1707- 1715 ,(2001) , 10.1200/JCO.2001.19.6.1707
S. Gwythen, G. Bolis, M. Gore, W. ten Bokkel Huinink, J. Verweij, I.R. Hudson, R. Despax, A. Jimŕnez-Lacave, Experience with independent radiological review during a topotecan trial in ovarian cancer Annals of Oncology. ,vol. 8, pp. 463- 468 ,(1997) , 10.1023/A:1008241127883